טוען...
Assessment of the anti-tumor potential of Bithionol in vivo using a xenograft model of ovarian cancer
OBJECTIVE: In regards to the concept of ‘drug repurposing’, we focused on pharmaceutical grade Bithionol (BT) as a therapeutic agent against ovarian cancer. Our recent in-vitro study provides preclinical data suggesting a potential therapeutic role for BT against recurrent ovarian cancer. BT was sho...
שמור ב:
| הוצא לאור ב: | Anticancer Drugs |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053334/ https://ncbi.nlm.nih.gov/pubmed/27058706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000364 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|